Inventor · disambiguated record
David D. Ho
Also filed as: HO DAVID · HO DAVID D · HO DAVID D S
21 granted patents·15 pending applications·287 citations·filing 1991–2024
95Inventor score
Files withUNIV COLUMBIA9UNIV ROCKEFELLER8AARON DIAMOND AIDS RES CENTER3CEDARS SINAI MEDICAL CENTER3ACADEMIA SINICA2
Top patents by PatentIndex Score
36 records- 0196US7923013B2Glycolipids and analogues thereof as antigens for NKT cellsUNIV ROCKEFELLER·Filed 2007·Granted Apr 12, 2011·34 cites·20 claims
- 0290US8637024B2Fusion antibodies for HIV therapyHO DAVID·Filed 2011·Granted Jan 28, 2014·14 cites·29 claims
- 0389US9587022B2Glycan-modified anti-CD4 antibody with improved HIV-1 neutralizing activityUNIV ROCKEFELLER·Filed 2013·Granted Mar 7, 2017·12 cites·2 claims
- 0489US6235504B1Methods for identifying genomic equivalent markers and their use in quantitating cells and polynucleotide sequences thereinUNIV ROCKEFELLER·Filed 2000·Granted May 22, 2001·78 cites·22 claims
- 0588US8163290B2Glycolipids and analogues thereof as antigens for NKT cellsTSUJI MORIYA·Filed 2010·Granted Apr 24, 2012·14 cites·19 claims
- 0686US7981428B2Flu vaccines and methods of use thereofACADEMIA SINICA·Filed 2009·Granted Jul 19, 2011·7 cites·17 claims
- 0781US10308707B2Bispecific HIV-1-neutralizing antibodiesAARON DIAMOND AIDS RES CENTER·Filed 2017·Granted Jun 4, 2019·2 cites·5 claims
- 0880US7534434B2Glycolipids and analogues thereof as antigens for NK T cellsUNIV ROCKEFELLER·Filed 2005·Granted May 19, 2009·5 cites·18 claims
- 0980US5178865AChinese herbal extracts in the treatment of hiv related disease in vitroCEDARS SINAI MEDICAL CENTER·Filed 1991·Granted Jan 12, 1993·53 cites·20 claims
- 1077US8030029B2Flu vaccines and methods of use thereofACADEMIA SINICA·Filed 2008·Granted Oct 4, 2011·1 cites·5 claims
- 1175US9790276B2Glycan-modified anti-CD4 antibodies for HIV prevention and therapyUNIV ROCKEFELLER·Filed 2013·Granted Oct 17, 2017·2 cites·10 claims
- 1273US9587012B2Bispecific HIV-1 neutralizing antibodiesAARON DIAMOND AIDS RES CENTER·Filed 2014·Granted Mar 7, 2017·2 cites·10 claims
- 1371US9884905B2Bispecific HIV-1 neutralizing antibodiesAARON DIAMOND AIDS RES CENTER·Filed 2017·Granted Feb 6, 2018·1 cites·6 claims
- 1468US2025026796A1Inhibitory peptides against coronavirusesUNIV COLUMBIA·Filed 2024·Application pending·0 cites
- 1566US6190871B1Immunoreagents reactive with a conserved epitope of human immunodeficiency virus type I (HIV-1) gp120 and methods of useCEDARS SINAI MEDICAL CENTER·Filed 1999·Granted Feb 20, 2001·15 cites·1 claims
- 1665US2024002476A1Potent neutralizing antibodies against sars-cov-2, generation and uses thereofUNIV COLUMBIA·Filed 2021·Application pending·0 cites
- 1765US2023203134A1Potent neutralizing antibodies against sars-cov-2, generation and uses thereofUNIV COLUMBIA·Filed 2021·Application pending·0 cites
- 1865US2023203138A1Potent neutralizing antibodies against sars-cov-2, generation and uses thereofUNIV COLUMBIA·Filed 2021·Application pending·0 cites
- 1960US2014186378A1Glycolipids and analogues thereof as antigens for nkt cellsSCRIPPS RESEARCH INST·Filed 2013·Application pending·0 cites
- 2059US12098187B2Bispecific HIV-1-neutralizing antibodiesUNIV COLUMBIA·Filed 2018·Granted Sep 24, 2024·0 cites·3 claims
- 2158US2025367225A17dw8-5 treatment for covid-19 and other virus-induced respiratory infectionsUNIV COLUMBIA·Filed 2023·Application pending·0 cites
- 2257US2024343781A1Characterization of potent and broadly neutralizing monoclonal antibodies against sars-cov-2, its variants, and related coronaviruses and methods of useUNIV COLUMBIA·Filed 2022·Application pending·0 cites
- 2356US2009233875A1Glycolipids and analogues thereof as antigens for nk t cellsUNIV ROCKEFELLER·Filed 2009·Application pending·0 cites
- 2455US8586051B2Glycolipids and analogues thereof as antigens for NKT cellsTSUJI MORIYA·Filed 2012·Granted Nov 19, 2013·0 cites·20 claims
- 2555US2024003880A1Monoclonal antibodies against sars-cov-2 nucleocapsid phosphoprotein and sandwich elisa methodUNIV COLUMBIA·Filed 2021·Application pending·0 cites
- 2654US12012451B2Engineering pH-dependent antigen binding activity into anti-HIV antibodies with improved pharmacokineticsUNIV ROCKEFELLER·Filed 2020·Granted Jun 18, 2024·0 cites·16 claims
- 2754US6298343B1Methods for intelligent universal database search enginesINVENTEC CORP·Filed 1997·Granted Oct 2, 2001·34 cites·21 claims
- 2854US2024228594A1Antibodies for the treatment and prevention of covid-19 and emerging variantsUNIV COLUMBIA·Filed 2022·Application pending·0 cites
- 2952US2009227658A1Methods and compositions for immunization against hivHUANG YAOXING·Filed 2003·Application pending·0 cites
- 3047US2004091498A1Defensins: use as antiviral agentsAARON DIAMOND AIDS RES CT·Filed 2003·Application pending·0 cites
- 3145US2008318204A1Highly-Sensitive Genomic Assays Employing Chimeric Bacteriophage StandardsZHANG LINQI·Filed 2002·Application pending·0 cites
- 3244US10654943B2Tri-specific antibodies for HIV therapyUNIV ROCKEFELLER·Filed 2016·Granted May 19, 2020·0 cites·8 claims
- 3343US2004096820A1Comparative proteomics of progressor and nonprogressor populationsCIPHERGEN BIOSYSTEMS INC·Filed 2003·Application pending·0 cites
- 3435US2003013124A1Surfaces for covalent attachment of ligandsFiled 2002·Application pending·0 cites
- 3533US6714906B1Rapid phase identification methodINVENTEC CORP·Filed 1999·Granted Mar 30, 2004·13 cites·18 claims
- 3632US6054284AImmunoreagents reactive with a conserved epitope of human immunodeficiency virus type I (HIV-1) GP120 and methods of useCEDARS SINAI MEDICAL CENTER·Filed 1997·Granted Apr 25, 2000·0 cites·2 claims
Join the waitlist — get patent alerts
Get an alert when David D. Ho files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →